Literature DB >> 23241891

PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway.

Kirsty F MacKenzie1, Kristopher Clark, Shaista Naqvi, Victoria A McGuire, Gesa Nöehren, Yosua Kristariyanto, Mirjam van den Bosch, Manikhandan Mudaliar, Pierre C McCarthy, Michael J Pattison, Patrick G A Pedrioli, Geoff J Barton, Rachel Toth, Alan Prescott, J Simon C Arthur.   

Abstract

The polarization of macrophages into a regulatory-like phenotype and the production of IL-10 plays an important role in the resolution of inflammation. We show in this study that PGE(2), in combination with LPS, is able to promote an anti-inflammatory phenotype in macrophages characterized by high expression of IL-10 and the regulatory markers SPHK1 and LIGHT via a protein kinase A-dependent pathway. Both TLR agonists and PGE(2) promote the phosphorylation of the transcription factor CREB on Ser(133). However, although CREB regulates IL-10 transcription, the mutation of Ser(133) to Ala in the endogenous CREB gene did not prevent the ability of PGE(2) to promote IL-10 transcription. Instead, we demonstrate that protein kinase A regulates the phosphorylation of salt-inducible kinase 2 on Ser(343), inhibiting its ability to phosphorylate CREB-regulated transcription coactivator 3 in cells. This in turn allows CREB-regulated transcription coactivator 3 to translocate to the nucleus where it serves as a coactivator with the transcription factor CREB to induce IL-10 transcription. In line with this, we find that either genetic or pharmacological inhibition of salt-inducible kinases mimics the effect of PGE(2) on IL-10 production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241891      PMCID: PMC3620524          DOI: 10.4049/jimmunol.1202462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  Transcriptional regulation of macrophage polarization: enabling diversity with identity.

Authors:  Toby Lawrence; Gioacchino Natoli
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.

Authors:  Joanna Mikita; Nadège Dubourdieu-Cassagno; Mathilde Sa Deloire; Antoine Vekris; Marc Biran; Gérard Raffard; Bruno Brochet; Marie-Hélène Canron; Jean-Michel Franconi; Claudine Boiziau; Klaus G Petry
Journal:  Mult Scler       Date:  2010-09-02       Impact factor: 6.312

Review 4.  Regulatory macrophages: setting the threshold for therapy.

Authors:  Bryan D Fleming; David M Mosser
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

Review 5.  Differential macrophage programming in the tumor microenvironment.

Authors:  Brian Ruffell; Nesrine I Affara; Lisa M Coussens
Journal:  Trends Immunol       Date:  2012-01-23       Impact factor: 16.687

6.  M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.

Authors:  Moniek Heusinkveld; Peggy J de Vos van Steenwijk; Renske Goedemans; Tamara H Ramwadhdoebe; Arko Gorter; Marij J P Welters; Thorbald van Hall; Sjoerd H van der Burg
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

7.  SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB.

Authors:  Tsutomu Sasaki; Hiroshi Takemori; Yoshiki Yagita; Yasukazu Terasaki; Tatsuya Uebi; Nanao Horike; Hiroaki Takagi; Teruo Susumu; Hiroshi Teraoka; Ken-Ichi Kusano; Osamu Hatano; Naoki Oyama; Yukio Sugiyama; Saburo Sakoda; Kazuo Kitagawa
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

8.  Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages.

Authors:  Sang-Hoon Kim; Carlos Henrique Serezani; Katsuhide Okunishi; Zbigniew Zaslona; David M Aronoff; Marc Peters-Golden
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

Review 9.  Macrophage heterogeneity and acute inflammation.

Authors:  Kate Liddiard; Marcela Rosas; Luke C Davies; Simon A Jones; Philip R Taylor
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

10.  The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes.

Authors:  Emma Henriksson; Helena A Jones; Kashyap Patel; Mark Peggie; Nicholas Morrice; Kei Sakamoto; Olga Göransson
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

View more
  110 in total

1.  Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells.

Authors:  Maria R Fernando; Mark A Giembycz; Derek M McKay
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

2.  G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b.

Authors:  Hong-Mei Li; Ji Hye Jang; Jun-Sub Jung; Jiseon Shin; Chul O Park; Yeon-Ja Kim; Won-Gyun Ahn; Ju-Suk Nam; Chang-Won Hong; Jongho Lee; Yu-Jin Jung; Jiang-Fan Chen; Katya Ravid; H Thomas Lee; Won-Ki Huh; Janusz H Kabarowski; Dong-Keun Song
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

3.  Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4.

Authors:  Bing Luan; Mark O Goodarzi; Naomi G Phillips; Xiuqing Guo; Yii-Der I Chen; Jie Yao; Matthew Allison; Jerome I Rotter; Reuben Shaw; Marc Montminy
Journal:  Cell Metab       Date:  2014-04-24       Impact factor: 27.287

4.  Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity.

Authors:  Tik Shing Cheung; Antonio Galleu; Malte von Bonin; Martin Bornhäuser; Francesco Dazzi
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

Review 5.  Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential.

Authors:  Marc N Wein; Marc Foretz; David E Fisher; Ramnik J Xavier; Henry M Kronenberg
Journal:  Trends Endocrinol Metab       Date:  2018-08-24       Impact factor: 12.015

6.  Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1.

Authors:  Melanie D Mumau; Ashley N Vanderbeck; Elizabeth D Lynch; Sophia B Golec; Stephen G Emerson; Jennifer A Punt
Journal:  J Immunol       Date:  2017-12-27       Impact factor: 5.422

7.  14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).

Authors:  Tim Sonntag; Joan M Vaughan; Marc Montminy
Journal:  FEBS J       Date:  2018-01-09       Impact factor: 5.542

8.  MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.

Authors:  Kirsty F MacKenzie; Mirjam W M Van Den Bosch; Shaista Naqvi; Suzanne E Elcombe; Victoria A McGuire; Alastair D Reith; Perry J Blackshear; Jonathan L E Dean; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

9.  Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Yueqin Liu; Asuncion Martinez-Anton; Hai-Yan Qi; Carolea Logun; Sara Alsaaty; Yong Hwan Park; Daniel L Kastner; Jae Jin Chae; James H Shelhamer
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

10.  Low molecular weight hyaluronan activates cytosolic phospholipase A2α and eicosanoid production in monocytes and macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Michael Eberlein; Asuncion Martinez-Anton; Yueqin Liu; Sara Alsaaty; Hai-Yan Qi; Carolea Logun; Maureen Horton; James H Shelhamer
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.